How can thromboembolic disease in pregnancy and the puerperium be prevented?
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901189348556800 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Prevention of thromboembolic disease in pregnancy and the puerperium involves anticoagulation, primarily using LMWH, guided by personalized risk assessments. Evidence supports this approach, though decision-making is complicated by limited data on the efficacy of prophylaxis and inconsistencies across guidelines. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18712259 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | How can thromboembolic disease in pregnancy and the puerperium be prevented? Tripdatabase thromboembolic disease pregnancy puerperium prevention obstetrics haematology risk factors maternal health Prevention of thromboembolic disease in pregnancy and the puerperium involves anticoagulation, primarily using LMWH, guided by personalized risk assessments. Evidence supports this approach, though decision-making is complicated by limited data on the efficacy of prophylaxis and inconsistencies across guidelines. |
| title | How can thromboembolic disease in pregnancy and the puerperium be prevented? |
| topic | thromboembolic disease pregnancy puerperium prevention obstetrics haematology risk factors maternal health |
| url | https://doi.org/10.5281/zenodo.18712259 |